Date:1/12/2009

ciated economic downturn; the Company's reliance on third party reimbursement policies to support the sales and market acceptance of its products, including the possible adverse impact of government regulation and changes in the availability and amount of reimbursement; the Company's ability to integrate its acquisitions and business combinations effectively; uncertainties inherent in the development of new products and the enhancement of existing products, including FDA approval and/or clearance and other regulatory risks, technical risks, cost overruns and delays; the risk that newly introduced products may contain undetected errors or defects or otherwise not perform as anticipated; manufacturing risks, including the Company's reliance on a single source of supply for key components, and the need to comply with especially high standards for the manufacture of many of its products; the Company's ability to predict accurately the demand for its products, and products under development, and to develop strategies to address its markets successfully; the early stage of market development for certain of the Company's products; the risk of adverse events and product liability claims; risks related to the use and protection of intellectual property; expenses and uncertainties relating to litigation; technical innovations that could render products marketed or under development by the Company obsolete; competition; general future legislative, regulatory, or tax changes; the risks of conducting business internationally, including the effect of exchange rate fluctuations on those operations; financing risks, including the Company's obligation to meet financial covenants and payment obligations under the Company's financing arrangements and leases; and the Company's ability to attract and retain qualified personnel.

The risks included above are not exhaustive. Other factors that could adversely affect the Company's business and prospec
'/>"/>

SOURCE Hologic, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7
Related medicine news :

1. Hologic, Inc. to Release First Quarter Fiscal 2009 Operating Results on Monday, February 2, 2009
2. Selflessness, core of all major world religions, has neuropsychological connection
3. Hologic to Present at the J.P. Morgan 27th Annual Healthcare Conference
4. Psychological Counseling Boosts Breast Cancer Outcomes
5. Psychological interventions associated with breast cancer survival
6. Hologic Announces Fourth Quarter and Fiscal 2008 Operating Results
7. Psychological study reveals that red enhances mens attraction to women
8. Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008
9. Gastric cancer with 3 pathological features
10. 9/11s Psychological Scars Slowly Healing
11. Hologic Announces Third Quarter Fiscal 2008 Operating Results